BLT 0.00% 2.6¢ benitec biopharma limited

Ann: HEPATITIS C TRIAL UPDATE, page-9

  1. 2,381 Posts.
    lightbulb Created with Sketch. 10
    Risiko, I have never heard of another company who reports on each and every patient it doses.

    Hopefully, this clarification will mean less volitility in the share price, leading to less panicked investors and ridicule from certain ex-shareholders that have sold out because they didn't understand the complexities of gene therapy trials.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.